Mediterranean Diet, Circuit Resistance Training, Empagliflozin in Elderly With Type 2 Diabetes: a Study Protocol

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT03560375

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03560375
Other papers using this trial's data
  • Clinical similarity, economic divergence: cost-effectiveness and population health implications of dietary, pharmacological, and exercise interventions in older adults with type 2 diabetes: a secondary analysis of a randomized controlled trial BMC geriatrics, 2026-07-25 DOI, PubMed 42902215, PMC13685177 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Israel (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03560375. Randomized; single masking; primary purpose treatment. Start 2018-05-09 (actual); primary completion 2021-02-10 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Mediterranean Diet, Circuit Resistance Training, Empagliflozin in Elderly With Type 2 Diabetes: a Study Protocol
Condition
Diabetes Mellitus, Type 2
Condition
Sarcopenia
Condition
Weight Loss
Intervention (Behavioral)
Circuit resistance training (CRT)
Intervention (Behavioral)
Vegeterranean diet (V-Med diet)
Intervention (Drug)
Empagliflozin 10 MG
Lead sponsor
Tel-Aviv Sourasky Medical Center (class: other government)

Record details

Record id
cardio:ct-nct03560375
Content hash
d9fc0f30ecc251db23e5c6c671274b66aa501f7ea4c5c59398c0f34e631890ac